Affordable Access

Mutations in AP3D1 associated with immunodeficiency and seizures define a new type of Hermansky-Pudlak syndrome.

Authors
  • Ammann, Sandra
  • Schulz, Ansgar
  • Krägeloh-Mann, Ingeborg
  • Dieckmann, Nele MG
  • Niethammer, Klaus
  • Fuchs, Sebastian
  • Eckl, Katja Martina
  • Plank, Roswitha
  • Werner, Roland
  • Altmüller, Janine
  • Thiele, Holger
  • Nürnberg, Peter
  • Bank, Julia
  • Strauss, Anne
  • von Bernuth, Horst
  • Zur Stadt, Udo
  • Grieve, Samantha
  • Griffiths, Gillian M
  • Lehmberg, Kai
  • Hennies, Hans Christian
  • And 1 more
Publication Date
Feb 25, 2016
Source
Apollo - University of Cambridge Repository
Keywords
Language
English
License
Unknown
External links

Abstract

Genetic disorders affecting biogenesis and transport of lysosome-related organelles are heterogeneous diseases frequently associated with albinism. We studied a patient with albinism, neutropenia, immunodeficiency, neurodevelopmental delay, generalized seizures, and impaired hearing but with no mutation in genes so far associated with albinism and immunodeficiency. Whole exome sequencing identified a homozygous mutation in AP3D1 that leads to destabilization of the adaptor protein 3 (AP3) complex. AP3 complex formation and the degranulation defect in patient T cells were restored by retroviral reconstitution. A previously described hypopigmented mouse mutant with an Ap3d1 null mutation (mocha strain) shares the neurologic phenotype with our patient and shows a platelet storage pool deficiency characteristic of Hermansky-Pudlak syndrome (HPS) that was not studied in our patient because of a lack of bleeding. HPS2 caused by mutations in AP3B1A leads to a highly overlapping phenotype without the neurologic symptoms. The AP3 complex exists in a ubiquitous and a neuronal form. AP3D1 codes for the AP3δ subunit of the complex, which is essential for both forms. In contrast, the AP3β3A subunit, affected in HPS2 patients, is substituted by AP3β3B in the neuron-specific heterotetramer. AP3δ deficiency thus causes a severe neurologic disorder with immunodeficiency and albinism that we propose to classify as HPS10. / This work was supported by grants EH 145/5-1 and SFB1160, TP1 (S.E.) and HE 3119/10-1 (H.C.H.) from the DFG, 01 EO 0803 (S.E.) from BMBF, by the K¨oln Fortune Program of the Faculty of Medicine, University of Cologne (H.C.H.), by grant 100140 from the Wellcome Trust, and by the National Institute for Health Research Biomedical Research Center (G.M.G.). / This is a metadata record relating to an article that cannot be shared due to publisher copyright.

Report this publication

Statistics

Seen <100 times